May 08, 2024 / 12:30PM GMT
Operator
(technical difficulty)And I will be your conference operator today. At this time, I would like to welcome everyone to the Q1 2024 Seres Therapeutics earnings conference call. (Operator Instructions)
Again, I would now like to turn the call over to Carlo Tanzi, Investor Relation. Please go ahead.
Carlo Tanzi - Seres Therapeutics Inc - IR
Thank you, and good morning. Our press release for the company's first quarter 2024 financial results and business update became available at 7 AM Eastern time this morning and can be found on the Investors & News section of the company's website.
I'd like to remind you that we will be making forward-looking statements, including about the potential for both, the timing and results of our clinical studies, future product candidates and development plans, our ability to generate additional capital, the sufficiency of cash to fund operations and other statements, all of which are not historical fact.
Actual results may differ materially. Additionally, these statements are subject to certain risks
Q1 2024 Seres Therapeutics Inc Earnings Call Transcript
May 09, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers